Crescita Therapeutics Inc. (TSX:CTX) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 1,821,616 common shares, representing 8.94% of the issued and outstanding share capital. The repurchased shares will be cancelled.

The repurchase program will be funded from resources available with the company. The bid is valid till August 30, 2024, or such earlier time as the company completes its purchases pursuant to the bid or provides notice of termination. As of August 27, 2023, the company had 20,374,153 common shares in issue and outstanding.